2016's Top IPOs
- BeiGene, Ltd. (BGNE) 15.25%
- Editas Medicine (EDIT) -19.94%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Mast Therapeutics (MSTX) to Offer Common Stock And Warrants
- Fieldpoint Petroleum (FPP) Files $20M Mixed Shelf
- Neos Therapeutics (NEOS) Withdraws $69M Common Stock Shelf
- Silver Spring Networks (SSNI) Files $200M Mixed Securities Shelf
- Ollie's Bargain Outlet Holdings (OLLI) Files 6.5M Common Stock Shelf for Shareholders
- See More
|11/19/2015||Axsome Therapeutics||AXSM||5.667 Mil||$9.00||$9.27||3.00%||Ladenburg Thalmann, Cantor Fitzgerald & Co., Brean Capital|
|2/3/2016||BeiGene, Ltd.||BGNE||6.6 Mil||$24.00||$27.66||15.25%||Goldman, Sachs & Co., Morgan Stanley and Cowen|
|11/20/2015||Duluth Holdings Inc.||DLTH||6.667 Mil||$12.00||$14.59||21.58%||William Blair, Baird, Raymond James, BMO Capital Markets|
|2/3/2016||Editas Medicine||EDIT||5.9 Mil||$16.00||$12.81||-19.94%||Morgan Stanley, JP Morgan, Cowen and JMP Securities.|
|11/13/2015||Mesoblast Limited||MESO||7.48 Mil||$8.00||$6.36||-20.50%||J.P. Morgan and Credit Suisse|
|11/19/2015||Mimecast Limited||MIME||7.75 Mil||$10.00||$9.60||-4.00%||Goldman, Sachs & Co.|
|11/19/2015||Match Group||MTCH||33.333 Mil||$12.00||$13.55||12.92%||J.P. Morgan, Allen & Company LLC, BofA Merrill Lynch|
|11/19/2015||Square||SQ||N/A||$9.00||$13.09||45.44%||Goldman, Sachs & Co., Morgan Stanley, JP Morgan|
|12/10/2015||Atlassian Corporation Plc||TEAM||22 Mil||$21.00||$30.08||43.24%||Goldman, Sachs & Co. and Morgan Stanley & Co. LLC|
|12/18/2015||Yirendai Ltd.||YRD||7.5 Mil||$10.00||$9.45||-5.50%||Morgan Stanley, Credit Susse, China Renaissance, Needham & Company|
|N/A||Antero Resources Corp.||AR||N/A||N/A||Barclays, Citigroup, J.P. Morgan, Credit Suisse, Jefferies, Wells Fargo Securities|
|N/A||Viking Therapeutics||VKTX||5 Mil||N/A||Oppenheimer & Co. and Roth Capital|
|N/A||Sidoti & Company, Inc.||SDTI||N/A||N/A||WR Hambrecht + Co., Sidoti & Company|
|N/A||Hailiang Education Group||HLG||N/A||N/A||Network 1 Financial Securities|
|N/A||HTG Molecular Diagnostics||HTGM||N/A||N/A||Leerink Partners|
|N/A||Nexvet||NVET||N/A||N/A||BofA Merrill Lynch and Cowen & Company|
|N/A||Klox Technologies, Inc.||KLOX||N/A||N/A||UBS Investment Bank, Canaccord Genuity, Needham & Company, National Bank of Canada Financial Inc.|
|N/A||Par Pharmaceutical Holdings, Inc.||PRX||N/A||N/A||J.P. Morgan, Goldman, Sachs & Co., Citigroup, Morgan Stanley, BofA Merrill Lynch, Deutsche Bank Securities, Evercore ISI, RBC Capital Markets, TPG Capital BD, LLC|
|N/A||ViewRay||VRAY||4 Mil||$12-$14||Cowen and Company, Stifel|
|N/A||Commercial Credit, Inc.||CCR||N/A||N/A||Keefe, Bruyette & Woods, JPMorgan|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.